Product details for CEACAM5 (Human) antibody
CEACAM5 (Human) antibody
Overview
|
|
| Antigen: | CEACAM5 (CEA, CD66e) |
| Antibody Type: | Monoclonal |
| Application: | Flow Cytometry (FACS), Cell-ELISA, Immunohistochemistry (IHC), ELISA, Western Blotting (WB) |
| Reactivity: | Human |
| Host: | Mouse |
| Quantity: | |
| Price: | 250,00 € (Plus shipping costs and VAT) |
| Order number: | ABIN108727 |
| Availability: | 1 to 2 days until shipment |
Additional Information: CEACAM5 (Human) antibody
| Antigen | CEACAM5 (CEA, CD66e) |
| Immunogen | TET2 was generated by immunisation of BALB/c mice with CEA partially purified from a perchloric acid extract from liver metastases of colonic tumors (3). The antibody was purified by protein G affinity chromatography from cell culture supernatants and is |
| Reactivity | Human |
| Antibody Type | Monoclonal |
| Format | Purified |
| Isotype | IgG1 »Matching secondary antibodies |
| Description | CEACAM5 (CEA-related cell adhesion molecule 5, CEA) belongs to the carcinoembryonic antigen (CEA) gene family (5). It encodes a glycosyl phosphatidylinositol (GPI)- linked glycoprotein with a Mr of 180,000-200,000 which is most strongly expressed on epithelial cells of the fetal and adult colon and to a minor extent on epithelial cells of the stomach and sweat glands, squamous epithelial cell of the tongue, esophagus and cervix. CEACAM5 is used as a tumor marker for early detection of recurrent disease due its expression in adenocarcinomas of the colon, lung, breast, stomach and pancreas and in mucinous ovarian carcinomas (5). Like all members of the CEACAM family, it consists of a single N domain, with structural homology to the immunoglobulin variable domains, followed by six immunoglobulin constant-like A (A1, A2, A3) and B domains (B1, B2, B3). |
| Clone | 26-3-13 |
| Host | Mouse |
| Specificity | TET2 is a broadly reactive antibody which reacts with most of the CEACAM molecules characterized to date (except CEACAM3, CEACAM4 and CEACAM7)4. TET2 can be used to detect CEACAM1 (BGP/CD66a), CEACAM5 (CEA/CD66e), CEACAM6 (NCA/CD66c) and CEACAM8 (CGM6/CD6 |
Application Details: CEACAM5 (Human) antibody
| Application | Flow Cytometry (FACS), Cell-ELISA, Immunohistochemistry (IHC), ELISA, Western Blotting (WB) |
| Application Notes | TET2 has been tested for the use in flow cytometry (1.2 ug/10^6 cells), cell-ELISA (1:200), ELISA (1:200 - 1:400), Western blots (4ug/ml) and immunohistology on cryosections (1-2 ug/10^6 cells). |
| Concentration | 1mg/ml |
| Purification | Protein G |
| Buffer | Phosphate buffered saline, pH 7.2 |
| Storage | Short term: 2°C - 8°C. Long term: -20°C (avoid repeated freezing and thawing) |
| Research Area | Receptors, Cancer, Receptors, Cell/Tissue Markers, Cancer |
| Restrictions | For research use only. Not for diagnostic or therapeutic use. Caution hazardous ingredient: Sodium azide, avoid exposure to skin and eyes, ingestion, and contact with heat, acids, and metals or metal ions. Wash exposed skin with soap and water. Flush eye |
Publications: CEACAM5 (Human) antibody
| Publications |
Baczy?ska, Wietrzyk, Madej et al.: "The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen (CEACAM5) expression." In: Cellular & molecular biology letters , Vol. 8, Issue 2, pp. 471-86, 2003/01 (PubMed) Zimmermann W (2002): "Carcinoembryonic antigen" In: In Wiley Encyclopedia of Molecular Medicine , pp. 459-462 Schoelzel, Zimmermann, Schwarzkopf et al.: "Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas." In: The American journal of pathology , Vol. 156, Issue 2, pp. 595-605, 2000/01 (PubMed) Hammarström S: "The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues." In: Semin. Cancer Biol. , Vol. 9, pp. 67-81 Grunert F, Stocks SC, Nagel G et al.: "CD66 family Workshop: Binding of myeloid blind panel antibodies and CD66 Subsection antibodies to HeLa transfectants expressing individual CD66 molecules." In: In Leukocyte Typing VI: White cell Differentiation Antigens T. Kishimoto et al., eds., Garland Publishing Inc., New York and London , pp. 1012-1025 Thompson, Moessinger, Reichardt et al.: "A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members." In: International journal of cancer. Journal international du cancer , Vol. 55, Issue 2, pp. 311-9, 1993/01 (PubMed) Strobel, Strobel, Bross et al.: "Effects of human bone marrow stroma on the growth of human tumor cells." In: Cancer research , Vol. 49, Issue 4, pp. 1001-7, 1989/01 (PubMed) Grunert, AbuHarfeil, Schwarz et al.: "Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns." In: International journal of cancer. Journal international du cancer , Vol. 36, Issue 3, pp. 357-62, 1985/01 (PubMed) Krop-Watorek, Laskowska, Salwa et al.: "CEA-related proteins on human urothelial cell lines of different transformation grades." In: Cancer letters , Vol. 139, Issue 1, pp. 15-22, 1999/01 (PubMed) |
Images: CEACAM5 (Human) antibody
|
Specificity testing of 26/3/13. Members of the CEA family were expressed on BOSC cells after transient transfection with expression vectors containing either the cDNA of CEACAM1, 5, 6, 7 or 8. Recognition of CEACAM3, 4 and of a recombinant transmembrane-
FACS analysis of BOSC23 cells using 26/3/13. BOSC23 cells were transiently transfected with an expres-sion vector encoding either CEACAM5 (red curve) or an irrelevant protein (control transfectant). Binding of 26/3/13 was detected witha PE conjugated sec |
External Information: CEACAM5 (Human) antibody
| Google Scholar | Find more references for clone 26-3-13 on Google Scholar™ |
| EMBL Harvester | Search human, mouse or rat genome for antigen CEACAM5 (CEA, CD66e) (Bioinformatic Harvester (EMBL)) |








